Heart valves for patients under 65
Search documents
Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Seeking Alphaยท 2025-09-10 21:03
Company Overview - Artivion is an aorta-focused company that specializes in heart valves for patients under the age of 65, along with products to treat aortic aneurysms and dissections [3] - The company has a revenue of over $400 million, with a midpoint guidance of $440 million for the current year and an EBITDA margin of approximately 20% [3] Financial Objectives - The company's goal is to achieve double-digit growth for the business in the foreseeable future and to grow EBITDA at twice the rate of sales [4] - Artivion has significant leverage opportunities, particularly in general and administrative expenses, which is common for companies of its size [4]